Clinical condition evaluation new system for predicting after-one-year physical dysfunction of rheumatoid arthritis patient

Abstract

The invention discloses a clinical condition evaluation new system for predicting after-one-year physical dysfunction of a rheumatoid arthritis patient. The new system is based on combination of a setof researched new indexes for predicting the after-one-year physical dysfunction of the rheumatoid arthritis patient, namely a limb muscle index (ASMI) and a body fat percentage (BF%). The new systemcan accurately screen the high-risk patient, the middle-risk patient and the low-risk patient in an aspect of after-one-year physical dysfunction, and furthermore the time can be earlier than prior art for nine months to one year. Furthermore different treatment plans are adopted so that intensive treatment can be performed on the high-risk patient and the middle-risk patient earlier for one yearor nine months, thereby more effectively preventing physical dysfunction of the RA patient, improving life quality of the patient, reducing economic loads of the patient, the family and the society,and realizing important meaning and high value in treatment controlling and monitoring of rheumatoid arthritis.

Description

technical field [0001] The invention belongs to the field of medical technology. More specifically, it relates to a new system of clinical condition assessment to predict physical dysfunction in patients with rheumatoid arthritis after 1 year. Background technique [0002] The incidence of rheumatoid arthritis (RA) in mainland China is about 0.42%, and the male to female prevalence rate is about 1:4. According to the results of the second national sample survey of disabled people in 2006, RA is the primary cause of physical disability among women in my country (9.4%). The high disability rate of RA seriously affects the work and living ability of patients. In 2013, a national multi-center survey on the disability and physical function limitation of patients with rheumatoid arthritis showed that the disease duration was <1 year, 1-<5 years, 5 years ~<10 years, 10~<15 years and ≥15 years patients had joint deformity with physical dysfunction rate were 5.41%, 18.63...

AI Technical Summary

Problems solved by technology

The above suggests that the target-reaching treatment guided by the disease activity score recommended by the current guidelines cannot effectively improve the joint structure damage and physical dysfunction in RA patients, especially those whose disease activity reaches the target after treatment. New and more effective indicators are urgently needed to improve RA in clinical practice. Disease assessment system to guide treatment, in order to more effectively maintain normal body functions or improve physical dysfunction, improve the quality of life of patients, and reduce the economic burden of patients, families and society

Images